ribociclib
novartis
['natalee', 'breast', ' ribo', 'ribociclib']
natalee study shows ribociclib cuts risk of most common form hr+/her2-ebc breast cancer from returning by 25%. received highly achieved idfs benefit to 27.7 months #asco2023 
Survivor of Ovarian Cancer/ Breast Cancer; Advocate on Disparities in Cancer Research and Treatment for African Americans, COVID19 and Supportive Care. #SASEP